Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology

Gut

Volumn 65, Issue 3, 2016, Pages 426-436

  Dao, Maria Carlota ^a,b,c   Everard, Amandine ^d   Aron Wisnewsky, Judith ^a,b,c   Sokolovska, Nataliya ^a,b,c   Prifti, Edi ^a   Verger, Eric O ^a,b,c   Kayser, Brandon D ^a   Levenez, Florence ^e,f   Chilloux, Julien ^g   Hoyles, Lesley ^g   Dumas, Marc Emmanuel ^g   Rizkalla, Salwa W ^a   Doré, Joel ^e,f   Cani, Patrice D ^d   Clément, Karine ^a,b,c   Le Mouhaër, Sylvie ^h   Cotillard, Aurélie ^h   Kennedy, Sean P ^h   Pons, Nicolas ^h   Le Chatelier, Emmanuelle ^h   Almeida, Mathieu ^h   Quinquis, Benoit ^h   Galleron, Nathalie ^h   Batto, Jean Michel ^h   Renault, Pierre ^h   Zucker, Jean Daniel ^h   Ehrlich, Stanislav Dusko ^h   Blottière, Hervé ^h   Leclerc, Marion ^h   Juste, Catherine ^h   De Wouters, Tomas ^h   Lepage, Patricia ^h   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Equipe Nutriomique: Nutrition et Obésité Approches Systémiques   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e University of Paris Saclay   (France)

^f UMR1319 MICALIS   (France)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; GLUCOSE; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AKKERMANSIA MUCINIPHILA; ARTICLE; BODY FAT DISTRIBUTION; CALORIC RESTRICTION; CLINICAL ARTICLE; CLINICAL TRIAL; FECES MICROFLORA; FEMALE; GENE RICHNESS; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; MALE; OBESITY; POPULATION ABUNDANCE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; AGED; BLOOD; DIET THERAPY; FECES; INSULIN RESISTANCE; INTESTINE FLORA; ISOLATION AND PURIFICATION; LOW CALORY DIET; METABOLISM; MICROBIOLOGY; MIDDLE AGED; TREATMENT OUTCOME; VERRUCOMICROBIA;

ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; DIET, REDUCING; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; TRIGLYCERIDES; VERRUCOMICROBIA;

EID: 84960253261     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-308778     Document Type: Article

References (65)

1. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012;489:242-9.
2. Delzenne NM, Cani PD. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 2011;31:15-31.
3. Cani PD. Metabolism in 2013: the gut microbiota manages host metabolism. Nat Rev Endocrinol 2014;10:74-6.
4. Ley RE, Bäckhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005;102:11070-5.
5. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013;341:1241214.
6. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.
7. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143:913-16.e7.
8. Png CW, Lindén SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010;105:2420-8.
9. Vigsnæs LK, Brynskov J, Steenholdt C, et al. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls. Benef Microbes 2012;3:287-97.
10. Swidsinski A, Dörffel Y, Loening-Baucke V, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011;60:34-40.
11. Joyce SA, Gahan CGM. The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol 2014;30:120-7.
12. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013;110:9066-71.
13. Shin N-R, Lee J-C, Lee H-Y, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014;63:727-35.
14. Anhê FF, Roy D, Pilon G, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 2014;64:872-83.
15. Zhang X, Shen D, Fang Z, et al. Human gut microbiota changes reveal the progression of glucose intolerance. PloS ONE 2013;8:e71108.
16. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55-60.
17. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013;498:99-103.
18. Khan MT, Nieuwdorp M, Bäckhed F. Microbial modulation of insulin sensitivity. Cell Metab 2014;20:753-60.
19. Aron-Wisnewsky J, Dore J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol 2012;9:590+.
20. Clarke SF, Murphy EF, Nilaweera K, et al. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 2012;3:186-202.
21. Cotillard A, Kennedy SP, Kong LC, et al. Dietary intervention impact on gut microbial gene richness. Nature 2013;500:585-8.
22. Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-6.
23. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009;106:2365-70.
24. Liou AP, Paziuk M, Luevano J-M, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013;5:178ra41.
25. Aron-Wisnewsky J, Clement K. The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep 2014;16:1-11.
26. Graessler J, Qin Y, Zhong H, et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J 2013;13:514-22.
27. Kong LC, Wuillemin P-H, Bastard J-P, et al. Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach. Am J Clin Nutr 2013;98:1385-94.
28. Ciangura C, Bouillot J-L, Lloret-Linares C, et al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obes Silver Spring Md 2010;18:760-5.
29. Dalmas E, Rouault C, Abdennour M, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr 2011;94:450-8.
30. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-72.
31. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2.
32. Disse E, Bastard JP, Bonnet F, et al. A lipid-parameter-based index for estimating insulin sensitivity and identifying insulin resistance in a healthy population. Diabetes Metab 2008;34:457-63.
33. Mutch DM, Tordjman J, Pelloux V, et al. Needle and surgical biopsy techniques differentially affect adipose tissue gene expression profiles. Am J Clin Nutr 2009;89:51-7.
34. Rizkalla SW, Prifti E, Cotillard A, et al. Differential effects of macronutrient content in 2 energy-restricted diets on cardiovascular risk factors and adipose tissue cell size in moderately obese individuals: a randomized controlled trial. Am J Clin Nutr 2012;95:49-63.
35. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature 2008;453:783-7.
36. Cotillard A, Poitou C, Torcivia A, et al. Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin-resistance after gastric bypass. J Clin Endocrinol Metab 2014;99:E1466-70.
37. Hirsch J, Gallian E. Methods for the determination of adipose cell size in man and animals. J Lipid Res 1968;9:110-19.
38. Aron-Wisnewsky J, Tordjman J, Poitou C, etal. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 2009;94:4619-23.
39. Dona AC, Jiménez B, Schäfer H, etal. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal Chem 2014;86:9887-94.
40. Blaise BJ, Shintu L, Elena B, etal. Statistical recoupling prior to significance testing in nuclear magnetic resonance based metabonomics. Anal Chem 2009;81:6242-51.
41. Nielsen HB, Almeida M, Juncker AS, et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol 2014;32:822-8.
42. Steyn NP, Nel JH, Nantel G, et al. Food variety and dietary diversity scores in children: are they good indicators of dietary adequacy? Public Health Nutr 2006;9:644-50.
43. Vieux F, Soler L-G, Touazi D, etal. High nutritional quality is not associated with low greenhouse gas emissions in self-selected diets of French adults. Am J Clin Nutr 2013;97:569-83.
44. Martin A. The "apports nutritionnels conseillés (ANC) " for the French population. Reprod Nutr Dev 2001;41:119-28.
45. Scutari M. Learning Bayesian Networks with the bnlearn R Package. J Stat Softw 2010;35:1-22.
46. Lukovac S, Belzer C, Pellis L, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio 2014;5:e01438-14.
47. Van Passel MWJ, Kant R, Zoetendal EG, et al. The Genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 2011;6:e16876.
48. Kong LC, Holmes BA, Cotillard A, et al. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLoS ONE; 2014;9:e109434.
49. Skurk T, Alberti-Huber C, Herder C, et al. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92:1023-33.
50. Abdul-Ghani MA, Matsuda M, Balas B, et al. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 2007;30:89-94.
51. Abdul-Ghani MA, Lyssenko V, Tuomi T, et al. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes. Diabetes Care 2009;32:281-6.
52. Russell WR, Hoyles L, Flint HJ, et al. Colonic bacterial metabolites and human health. Curr Opin Microbiol 2013;16:246-54.
53. Frost G, Sleeth ML, Sahuri-Arisoylu M, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun 2014;5:3611.
54. Samuel BS, Hansen EE, Manchester JK, et al. Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut. Proc Natl Acad Sci USA 2007;104:10643-8.
55. Toivonen RK, Emani R, Munukka E, etal. Fermentable fibres condition colon microbiota and promote diabetogenesis in NOD mice. Diabetologia 2014;57:2183-92.
56. Ganesh BP, Klopfleisch R, Loh G, et al. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PloS ONE 2013;8:e74963.
57. Reunanen J, Kainulainen V, Huuskonen L, et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of epithelial cell layer. Appl Environ Microbiol 2015;813655-62.
58. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009;1:6ra14.
59. Everard A, Lazarevic V, Derrien M, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011;60:2775-86.
60. Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015;64:93-100.
61. Jakobsdottir G, Xu J, Molin G, et al. High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PloS ONE 2013;8:e80476.
62. Van den Abbeele P, Roos S, Eeckhaut V, et al. Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli. Microb Biotechnol 2012;5:106-15.
63. O'Connor A, Quizon PM, Albright JE, et al. Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. Mamm Genome 2014;25:583-99.
64. Kato LM, Kawamoto S, Maruya M, et al. The role of the adaptive immune system in regulation of gut microbiota. Immunol Rev 2014;260:67-75.
65. Zhang H, Sparks JB, Karyala SV, et al. Host adaptive immunity alters gut microbiota. ISME J 2015;9:770-81.